ERYTECH Pharma S.A.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$228,000 over the previous period. Total operating expenses were $27,147,000.

Profit Margin

ERYTECH Pharma S.A. (NASDAQ:ERYP): Profit margin
2013 1.80M -8.14M -451.92%
2014 6.61M -8.86M -133.98%
2015 10.77M -15.01M -139.32%
2016 19.71M -21.91M -111.13%
2017 3.36M -33.53M -996.73%
2018 4.13M -38.22M -923.73%
2019 3.36M -62.65M -1862.63%
2020 0 -73.3M
2021 0 -53.79M
2022 0 -228K

ERYP Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
0003.36M4.13M3.36M19.71M10.77M6.61M1.80M
Cost of revenue
0057.58M52.19M33.46M25.46M19.71M10.77M6.61M5.32M
Gross profit
00-57.58M-48.82M-29.33M-22.09M000-3.52M
Operating exp.
Research and development
19.90M45.1M57.58M52.19M-19.72M-25.46M0002.50M
Selling and marketing
0000000000
Total operating expenses
27.14M56.51M68.83M64.07M10.15M5.42M2.67M4.80M2.33M1.75M
Operating income
-2.79M-56.51M-68.83M-64.07M-43.62M-30.88M-22.39M-15.58M-8.94M-7.08M
Other income (expenses), net
3.08M2.72M-4.46M1.41M5.39M-2.64M488K567K68.17K-1.09M
Income before tax
293K-53.79M-73.29M-62.66M-38.22M-33.53M-21.90M-15.01M-8.88M-8.18M
Income tax expense
521K2K3K-1K2K-3K10K-3K-20.15K-40.01K
Net income
-228K-53.79M-73.3M-62.65M-38.22M-33.53M-21.91M-15.01M-8.86M-8.14M
Earnings per share
Basic EPS
-0.00-2.27-3.99-3.49-2.13-1.87-2.74-2.16-1.51-1.74
Diluted EPS
-0.00-2.27-3.99-3.49-2.13-1.87-2.74-2.16-1.51-1.74
Data sourceData sourceData sourceData sourceData source